Cognito Therapeutics
Signal active
Organization
Contact Information
Overview
Cognito Therapeutics is a clinical-stage neurotechnology business focused on creating disease-modifying pharmaceutical methods for the treatment of neurodegenerative illnesses. Li-Huei Tsai and Ed Boyden, MIT Professors, and scientific founders, created its non-invasive neuromodulation platform. The Company's primary therapy is now being studied in a pivotal study for Alzheimer's Disease and has been designated as a Breakthrough Device by the FDA.
About
Industries
Biotechnology, Health Care, Medical Device, Therapeutics, Health Diagnostics
Founded
2016
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cognito Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $13.0B in funding across 60 round(s). With a team of 11-50 employees, Cognito Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Cognito Therapeutics, raised $35.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$216.8M
Details
2
Cognito Therapeutics has raised a total of $216.8M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 73.0M | ||
| 2024 | Early Stage Venture | 35.0M |
Investors
Cognito Therapeutics is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cognito Therapeutics | - | FUNDING ROUND - Cognito Therapeutics | 108.8M |
| OpAmp Capital | - | FUNDING ROUND - OpAmp Capital | 108.8M |
| Cognito Therapeutics | - | FUNDING ROUND - Cognito Therapeutics | 35.0M |
| FoundersX Ventures | - | FUNDING ROUND - FoundersX Ventures | 35.0M |
Recent Activity
There is no recent news or activity for this profile.